Five of the Royce SMid-Cap Total Return Fund portfolio’s nine equity sectors made a positive impact on calendar year ...

Royce SMid-Cap Total Return Fund was up 4.0% in 2025 versus a gain of 11.9% for its benchmark, Russell 2500 Index, for the ...

Its true value depends not on the number of detected features but on the reliability of metabolite identification and pathway analysis. Despite well-established guidelines, annotation and definitive ...

Company to engage industry partners and distribution channels as part of expanding BioCosmeceutical commercialization strategyMELVILLE, N.Y., ...

Learn the essential criteria for medical device commercialization in 2026, from AI to global compliance and market trends.

Families in Odisha's Manikapur village anxiously cope with the effects of war in West Asia, impacting their migrant relatives in the Gulf.

For a nation now grappling with the opening salvos of “Operation Epic Fury,” the sight of six flag-draped transfer cases was a visceral reminder of the human cost of modern warfare. This “dignified ...

SGT-003 in the INSPIRE DUCHENNE trial to date - - Robust microdystrophin expression with consistent mechanistic evidence of dystrophin associated protein complex (DAPC) restoration and improvements in ...

Modernizing biomanufacturing methods and reducing regulatory burdens are key landmarks on India’s roadmap for expanding biosimilars development.

SGT-003 in the INSPIRE DUCHENNE trial to date - - Robust microdystrophin expression with consistent mechanistic evidence of dystrophin associated protein complex ...

Q4 Revenue Grew 27% Year-Over-Year to Record $14.5 Million Q4 Operating Income of $1.9 Million; Adjusted EBITDA Increased by 53% to $2.3 Million, Reflecting Significant Operating Leverage Full Year ...